Rare disease specialist SynaptixBio Ltd has got its second FDA orphan drug designation for a subtype of TUBB4A...
Up To Date
Latest News
Pierre Fabre Médicament SAS has entered into an Asset Purchase Agreement (APA) over pan-RAF programs developed...
Bayer AG has purchased European commercialisation rights for the transthyretin amyloid cardiomyopathy...
PulseSight Therapeutics SAS was launched on Wednesday, backed by seed financing from Pureos Bioventures and ND...
Swiss multivalent vaccine developer LimmaTech Biologics AG has been awarded US$2.2m rom the Combating...
Intracellular cancer target screening specialist Curve Therapeutics Ltd has closed a £40.5m financing led by...